ArticleCellular & molecular biology letters2026

GPNMB-ECD drives acquired resistance to osimertinib in NSCLC via inducing tumor cell cytoskeletal reorganization.

Min Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.